Document ID: chunk:federal_register_of_legislation:F2025C00158:clause:4_1:p99
Version: federal_register_of_legislation:F2025C00158
Segment Type: clause
Provision Reference: sch 4 cl 1 (pt 99/191)
Character Range: 10632796–10650111

Gastro-oesophageal reflux disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Compliance with Authority Required procedures - Streamlined Authority Code 8774
                                                                                                                                                                                                                               The treatment must be for initial treatment of symptomatic gastro-oesophageal reflux disease.  or
                                                    Lansoprazole                                                                                                                                                               The treatment must be for the short-term maintenance treatment of gastro-oesophageal reflux disease.

                                                    Omeprazole

                                                    Pantoprazole

                                                    Rabeprazole

C8775               P8775          CN8775           Esomeprazole                                                                                                                                                               Peptic ulcer                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             Compliance with Authority Required procedures - Streamlined Authority Code 8775
                                                                                                                                                                                                                               Initial treatment
                                                    Lansoprazole                                                                                                                                                               Patient must have tested negative for helicobacter pylori infection.  or
                                                                                                                                                                                                                               Patient must have failed treatment with helicobacter pylori eradication therapy.
                                                    Omeprazole

                                                    Pantoprazole

                                                    Rabeprazole

C8776               P8776          CN8776           Esomeprazole                                                                                                                                                               Gastro-oesophageal reflux disease                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        Compliance with Authority Required procedures - Streamlined Authority Code 8776
                                                                                                                                                                                                                               The treatment must be for long-term maintenance of gastro-oesophageal reflux disease in a patient with symptoms inadequately controlled using a low dose proton pump inhibitor.
                                                    Lansoprazole

                                                    Omeprazole

                                                    Pantoprazole

                                                    Rabeprazole

C8777               P8777          CN8777           Esomeprazole                                                                                                                                                               Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures
                                                                                                                                                                                                                               Patient must have symptoms which are inadequately controlled using a standard dose proton pump inhibitor.
C8778               P8778          CN8778           Esomeprazole                                                                                                                                                               Scleroderma oesophagus                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures
                                                                                                                                                                                                                               Patient must have symptoms which are inadequately controlled using a standard dose proton pump inhibitor.
C8780               P8780          CN8780           Esomeprazole                                                                                                                                                               Scleroderma oesophagus                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 8780

                                                    Lansoprazole

                                                    Omeprazole

                                                    Pantoprazole

                                                    Rabeprazole

C8813               P8813          CN8813           Lacosamide                                                                                                                                                                 Intractable partial epileptic seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 8813
                                                                                                                                                                                                                               Initial treatment
                                                                                                                                                                                                                               Must be treated by a neurologist; AND
                                                                                                                                                                                                                               The treatment must be in combination with two or more anti-epileptic drugs which includes one second-line adjunctive agent; AND
                                                                                                                                                                                                                               The condition must have failed to be controlled satisfactorily by other anti-epileptic drugs, which includes at least one first-line anti-epileptic agent and at least two second-line adjunctive anti-epileptic agents; AND
                                                                                                                                                                                                                               The treatment must be for dose titration purposes.
C8815               P8815          CN8815           Lacosamide                                                                                                                                                                 Intractable partial epileptic seizures                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   Compliance with Authority Required procedures - Streamlined Authority Code 8815
                                                                                                                                                                                                                               Continuing treatment
                                                                                                                                                                                                                               Patient must have previously received PBS-subsidised treatment with this drug for this condition.
C8822               P8822          CN8822           Botulinum toxin type A purified neurotoxin complex                                                                                                                         Dynamic equinus foot deformity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           Compliance with Authority Required procedures - Streamlined Authority Code 8822
                                                                                                                                                                                                                               The condition must be due to spasticity; AND
                                                    Clostridium botulinum type A toxin - haemagglutinin complex                                                                                                                Patient must have cerebral palsy; AND
                                                                                                                                                                                                                               Patient must be ambulant;
                                                                                                                                                                                                                               Patient must be aged 18 years or older;
                                                                                                                                                                                                                               Must be treated by a neurologist.  or
                                                                                                                                                                                                                               Must be treated by an orthopaedic surgeon.  or
                                                                                                                                                                                                                               Must be treated by a paediatrician.  or
                                                                                                                                                                                                                               Must be treated by a rehabilitation specialist.
C8827               P8827          CN8827           Esomeprazole                                                                                                                                                               Pathological hypersecretory conditions including Zollinger-Ellison syndrome and idiopathic hypersecretion                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                Compliance with Authority Required procedures - Streamlined Authority Code 8827

C8830               P8830          CN8830           Ixekizumab                                                                                                                                                                 Severe chronic plaque psoriasis                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          Compliance with Written Authority Required